HRA Pharma reports sales up by a quarter in 2021
Premium
7 March 2022
French consumer healthcare company HRA Pharma reported sales up by 26.0% in 2021.
Industry News
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
HRA Pharma reports sales up by a quarter in 2021
GSK announces demerger date and sets out strategy
Premium
3 March 2022
GlaxoSmithKline (GSK) expects to demerge its Consumer Healthcare business as Haleon in July 2022, and has set out how the standalone company plans to achieve “above-market sales growth”.
Haleon will target greater household penetration
Premium
3 March 2022
Increasing household penetration for its brands will be the “largest opportunity” for GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, according to Brian McNamara, chief executive officer designate of Haleon.
Switches and naturals are high on Haleon’s agenda
Premium
3 March 2022
Switching medicines from prescription to non-prescription status and launching naturals will be high on the agenda at GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, says Brian McNamara, chief executive officer designate of Haleon.
Orkla boosts VMS presence with Healthspan deal
Premium
2 March 2022
Orkla has boosted its presence in vitamins, minerals and supplements (VMS) by acquiring UK-based Healthspan Group in a deal worth up to GBP85 million (USD112 million).
Bayer highlights innovations as sales rise by 6.5%
2 March 2022
Bayer said its Consumer Health division was “accelerating growth with innovation” as it reported worldwide sales up by 6.5% on a currency- and portfolio-adjusted basis to EUR5.29 billion (USD5.84 billion) in 2021.
Stada welcomes German decision on doxylamine
Premium
2 March 2022
Stada has welcomed a decision by the German health ministry to allow the antihistamine doxylamine to remain available without a prescription for use by people of all ages with sleep disorders, including those aged 65 years and older.
Unilever to take ‘measured’ approach in consumer health
Premium
2 March 2022
Unilever remains keen to expand its presence in health, beauty and hygiene following the failed bid for GlaxoSmithKline (GSK) Consumer Healthcare, says chief executive officer Alan Jope, but the company will be “measured in how we get there”.
Stada expands Lemocin sore-throat brand in Germany
Premium
2 March 2022
Stada has expanded its Lemocin sore-throat medicine in Germany and received confirmation from the German health ministry that the original formulation containing the antibiotic mixture tyrothricin can remain available without a prescription.
Beiersdorf’s Consumer sales rise by 8.8% in 2021
Premium
2 March 2022
Beiersdorf’s Consumer division reported worldwide sales up by 8.8% on an organic basis to EUR6.13 billion (USD6.73 billion) in 2021, following strong growth in e-commerce sales.